Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Jusufovic (Tuzla, Bosnia and Herzegovina), V. Zugic (Belgrade, Republic of Serbia), M. Kosnik (Ljubljana, Slovenia), M. Jovancevic Drvenica (Sremska Kamenica, Republic of Serbia), S. Hromis (Sremska Kamenica, Republic of Serbia), J. Nurkic (Kuwait City, Kuwait), M. Al-Ahmad (Kuwait City, Kuwait), L. Bulat Kardum (Rijeka, Croatia), R. Sejdinovic (Tesanj, Bosnia and Herzegovina), B. Prnjavorac (Tesanj, Bosnia and Herzegovina), A. Jusufovic (Tuzla, Bosnia and Herzegovina). Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study. 544

Member's Comments

No comment yet.

Related content which might interest you: Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis Source: International Congress 2018 – COPD management Year: 2018 The Effect of MK-7264, a P2X3 antagonist, on Cough Reflex Sensitivity in a Randomized Crossover Trial of Healthy and Chronic Cough Subjects Source: International Congress 2017 – New ideas for the management of chronic lung diseases Year: 2017 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Effects of Regular Use of ß2-Adrenergic Receptor Agonists on the Risk of Parkinson’s Disease in Patients with COPD Source: International Congress 2019 – More and more COPD Year: 2019 Short-term Impact of Lung Flute and Inspiratory Muscle Trainer on Pulmonary Functions and Functional Capacity in COPD from a Low Middle Income Country : A Pilot Randomized Control Trial. Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 Impact of Covid-19 Pneumonia on Pulmonary Function, Functional Exercise Capacity and Quality of Life Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2) Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis Year: 2020 Perception and Usage Among Indian Physicians of Long Acting Dual Bronchodilators in COPD: PATTERN Study Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Forced Vital Capacity and Quality of Life: BOLD Study Cross-Sectional Analysis Source: Virtual Congress 2021 – Patient-reported outcomes in respiratory disease Year: 2021 Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting - A Cross-sectional Study of Adult Asthma Patients in Japan: ACQUIRE-2 Source: International Congress 2017 – Clinical points to ponder in asthma Year: 2017 Effect of Vaping on Airway Barrier Function: A Pilot Study Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients. Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection Year: 2019 Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018